International Clinical Trial: A Clinical Study on the Use of Yuyang Mouthwash for the Prevention of Grade =2 Sacituzumab Govitecan-Associated Oral Mucositis

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114861) titled 'A Clinical Study on the Use of Yuyang Mouthwash for the Prevention of Grade =2 Sacituzumab Govitecan-Associated Oral Mucositis' on Dec. 18, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Beijing Luhe Medical College Affiliated to Capital Medical University

Condition: oral mucositis

Intervention: Clinical Trial Group:Yuyang mouthwash 10-15 mL twice daily rinse for 30 s and expectorate (do not swallow). Start before the first dose of sacituzumab govitecan. Positive control group:Kangfuxin solution 10 mL three times daily

Recruitment Status: Not Recruiting

Phase: N/A

Date ...